Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

519.40INR
3:59pm IST
Change (% chg)

Rs-12.30 (-2.31%)
Prev Close
Rs531.70
Open
Rs534.10
Day's High
Rs540.20
Day's Low
Rs516.80
Volume
25,348,260
Avg. Vol
12,868,148
52-wk High
Rs541.00
52-wk Low
Rs312.00

Latest Key Developments (Source: Significant Developments)

Sun Pharma Unit To Acquire Aquinox Pharmaceuticals (Canada)
Wednesday, 29 Jul 2020 

July 29 (Reuters) - Sun Pharmaceutical Industries Ltd ::TARO PHARMACEUTICAL INDUSTRIES AGREED TO ACQUIRE BY WAY OF PURCHASE OF ALL OUTSTANDING SHARES OF AQUINOX PHARMACEUTICALS.SAYS DEAL FOR $8.2 MILLION.  Full Article

Sun Pharma, Hikma Sign Exclusive Licensing Deal For Ilumya For MENA Region
Monday, 15 Jun 2020 

June 15 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMA AND HIKMA ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR ILUMYA FOR MIDDLE EAST & NORTH AFRICA REGIONS.HIKMA WILL BE RESPONSIBLE FOR REGISTRATION AND COMMERCIALIZATION OF PRODUCT IN ALL MENA MARKETS.SUN PHARMA WILL BE RESPONSIBLE FOR PRODUCT SUPPLY.IS ELIGIBLE FOR UPFRONT AND MILESTONE PAYMENTS FROM HIKMA.TERM OF THIS AGREEMENT IS 15 YEARS FROM FIRST SALE, WITH TWO YEARS' AUTOMATIC RENEWAL PERIODS.  Full Article

India's Sun Pharmaceutical Industries March Qtr Consol Net PAT Falls
Wednesday, 27 May 2020 

May 27 (Reuters) - Sun Pharmaceutical Industries Ltd ::MARCH-QUARTER CONSOL NET PAT 4 BILLION RUPEES VERSUS PROFIT OF 6.36 BILLION RUPEES YEAR AGO.RECOMMENDED FINAL DIVIDEND OF 1 RUPEE/SHARE.MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 81.85 BILLION RUPEES VERSUS 71.64 BILLION RUPEES YEAR AGO.  Full Article

India's Sun Pharma To Buy Back Shares For Up To 17 Bln Rupees
Tuesday, 17 Mar 2020 

March 17 (Reuters) - Sun Pharmaceutical Industries Ltd ::TO BUY-BACK SHARES AT A MAXIMUM PRICE OF 425 RUPEES PER SHARE.BUYBACK FOR MAXIMUM AMOUNT OF UP TO 17 BILLION RUPEES.  Full Article

Sun Pharma To Consider Share Buyback On March 17 - Statement
Thursday, 12 Mar 2020 

March 12 (Reuters) - Sun Pharmaceutical Industries Ltd ::TO CONSIDER SHARE BUYBACK ON MARCH 17 - STATEMENT.  Full Article

India's Sun Pharma Launches RIOMET ER Oral Suspension In The U.S.
Wednesday, 26 Feb 2020 

Feb 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::LAUNCHES RIOMET ER ORAL SUSPENSION IN THE U.S..LABEL FOR RIOMET ER CARRIES BOXED WARNING ABOUT RISK OF LACTIC ACIDOSIS WITH EXCESSIVE ALCOHOL INTAKE.  Full Article

India's Sun Pharmaceutical Industries Dec Qtr Consol Net PAT Falls
Thursday, 6 Feb 2020 

Feb 6 (Reuters) - Sun Pharmaceutical Industries Ltd ::DEC-QUARTER CONSOL NET PAT 9.14 BILLION RUPEES VERSUS PROFIT OF 12.42 BILLION RUPEES YEAR AGO.DEC-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 81.55 BILLION RUPEES VERSUS 77.40 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 3 RUPEES PER SHARE.  Full Article

India's Sun Pharma Introduces ABSORICA LD Capsules For Acne Treatment In U.S.
Tuesday, 4 Feb 2020 

Feb 4 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMACEUTICAL INDUSTRIES - INTRODUCES ABSORICA LD (ISOTRETINOIN) CAPSULES FOR MANAGEMENT OF SEVERE RECALCITRANT NODULAR ACNE IN U.S..  Full Article

India's Sun Pharma Gets Form 483 From US FDA With Observations For Halol Unit- ET Now
Friday, 20 Dec 2019 

Dec 20 (Reuters) - :GETS FORM 483 FROM US FDA WITH OBSERVATIONS FOR ITS HALOL UNIT- ET NOW.SHARES FALL OVER 1% IN AFTERNOON TRADE.  Full Article

FDA Approves First Generics Of Gilenya
Friday, 6 Dec 2019 

Dec 5 (Reuters) - U.S. Food and Drug Administration::FDA APPROVES FIRST GENERICS OF GILENYA.U.S. FDA - APPROVED 3 APPLICATIONS FOR FIRST GENERICS OF GILENYA CAPSULES FOR TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS IN ADULT PATIENTS.U.S. FDA - GRANTED APPROVALS OF GENERIC GILENYA (FINGOLIMOD) APPLICATIONS TO HEC PHARM CO LTD, BIOCON LTD AND SUN PHARMACEUTICAL INDUSTRIES LTD.  Full Article

ICRA ratings for Indian debt instruments-Jul 30

Jul 30 - Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of July 29, 2020. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: ------------------- Asian Handicrafts Pvt Ltd ST – Fund Bas